Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Role of Exenterative Surgery in Advanced Urological Neoplasms

The Role of Exenterative Surgery in Advanced Urological Neoplasms Pelvic exenterative surgery is both complex and challenging, especially in the setting of locally recurrent disease. In recent decades, improved surgical techniques have facilitated more extensive resection of both locally advanced and recurrent pelvic malignancies, but its role in urological cancer surgery is highly selective. However, it remains an important part of the armamentarium for the management of bladder and prostate cancer cases where there is local invasion into adjacent organs or localized recurrence. Better diagnostics, reconstructive options and centralized care have reduced associated morbidity considerably, and it is still used rarely in palliative settings. Despite this, there is sparse prospective evidence reporting on long-term oncological or quality of life outcomes. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Urology Karger

The Role of Exenterative Surgery in Advanced Urological Neoplasms

Loading next page...
 
/lp/karger/the-role-of-exenterative-surgery-in-advanced-urological-neoplasms-lraGrKkCgS

References (83)

Publisher
Karger
Copyright
© 2020 The Author(s) Published by S. Karger AG, Basel
ISSN
1661-7649
eISSN
1661-7657
DOI
10.1159/000499258
Publisher site
See Article on Publisher Site

Abstract

Pelvic exenterative surgery is both complex and challenging, especially in the setting of locally recurrent disease. In recent decades, improved surgical techniques have facilitated more extensive resection of both locally advanced and recurrent pelvic malignancies, but its role in urological cancer surgery is highly selective. However, it remains an important part of the armamentarium for the management of bladder and prostate cancer cases where there is local invasion into adjacent organs or localized recurrence. Better diagnostics, reconstructive options and centralized care have reduced associated morbidity considerably, and it is still used rarely in palliative settings. Despite this, there is sparse prospective evidence reporting on long-term oncological or quality of life outcomes.

Journal

Current UrologyKarger

Published: Jan 1, 2020

Keywords: Advanced pelvic malignancies; Pelvic exenteration; Bladder cancer; Prostate cancer; Surgical outcomes

There are no references for this article.